SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses.
Mazzetti P, Spezia PG, Capria AL, Freer G, Sidoti M, Costarelli S, Cara A, Rosellini A, Frateschi S, Moscato G, Franconi I, Curcio M, Vatteroni ML, Lai M, Quaranta P, Focosi D, Sani S, Pistello M.
Mazzetti P, et al.
J Clin Virol Plus. 2023 Jun;3(2):100149. doi: 10.1016/j.jcvp.2023.100149. Epub 2023 Apr 21.
J Clin Virol Plus. 2023.
PMID: 37128202
Free PMC article.
No abstract available.